The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow A correction has been published
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by He, B.
Right arrow Articles by Cerutti, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by He, B.
Right arrow Articles by Cerutti, A.
The Journal of Immunology, 2004, 172: 3268-3279.
Copyright © 2004 by The American Association of Immunologists

Lymphoma B Cells Evade Apoptosis through the TNF Family Members BAFF/BLyS and APRIL1

Bing He*, Amy Chadburn*, Erin Jou*, Elaine J. Schattner{dagger}, Daniel M. Knowles* and Andrea Cerutti2,*,{ddagger}

Departments of * Pathology and Laboratory Medicine and {dagger} Medicine, Weill Medical College, and {ddagger} Immunology Graduate Program, Weill Graduate School of Medical Sciences, Cornell University, New York, NY 10021

The mechanisms underlying the autonomous accumulation of malignant B cells remain elusive. We show in this study that non-Hodgkin’s lymphoma (NHL) B cells express B cell-activating factor of the TNF family (BAFF) and a proliferation-inducing ligand (APRIL), two powerful B cell-activating molecules usually expressed by myeloid cells. In addition, NHL B cells express BAFF receptor, which binds BAFF, as well as transmembrane activator and calcium modulator and cyclophilin ligand interactor (TACI) and B cell maturation Ag (BCMA), which bind both BAFF and APRIL. Neutralization of endogenous BAFF and APRIL by soluble TACI and BCMA decoy receptors attenuates the survival of NHL B cells, decreases activation of the prosurvival transcription factor NF-{kappa}B, down-regulates the antiapoptotic proteins Bcl-2 and Bcl-xL, and up-regulates the proapoptotic protein Bax. Conversely, exposure of NHL B cells to recombinant or myeloid cell-derived BAFF and APRIL attenuates apoptosis, increases NF-{kappa}B activation, up-regulates Bcl-2 and Bcl-xL, and down-regulates Bax. In some NHLs, exogenous BAFF and APRIL up-regulate c-Myc, an inducer of cell proliferation; down-regulate p53, an inhibitor of cell proliferation; and increase Bcl-6, an inhibitor of B cell differentiation. By showing that nonmalignant B cells up-regulate BAFF and APRIL upon stimulation by T cell CD40 ligand, our findings indicate that NHL B cells deregulate an otherwise physiological autocrine survival pathway to evade apoptosis. Thus, neutralization of BAFF and APRIL by soluble TACI and BCMA decoy receptors could be useful to dampen the accumulation of malignant B cells in NHL patients.




This article has been cited by other articles:


Home page
BloodHome page
M. Gupta, S. R. Dillon, S. C. Ziesmer, A. L. Feldman, T. E. Witzig, S. M. Ansell, J. R. Cerhan, and A. J. Novak
A proliferation-inducing ligand mediates follicular lymphoma B-cell proliferation and cyclin D1 expression through phosphatidylinositol 3-kinase-regulated mammalian target of rapamycin activation
Blood, May 21, 2009; 113(21): 5206 - 5216.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. J. Novak, S. L. Slager, Z. S. Fredericksen, A. H. Wang, M. M. Manske, S. Ziesmer, M. Liebow, W. R. Macon, S. R. Dillon, T. E. Witzig, et al.
Genetic Variation in B-Cell-Activating Factor Is Associated with an Increased Risk of Developing B-Cell Non-Hodgkin Lymphoma
Cancer Res., May 15, 2009; 69(10): 4217 - 4224.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
L. Fu, Y.-C. Lin-Lee, L. V. Pham, A. T. Tamayo, L. C. Yoshimura, and R. J. Ford
BAFF-R promotes cell proliferation and survival through interaction with IKK{beta} and NF-{kappa}B/c-Rel in the nucleus of normal and neoplastic B-lymphoid cells
Blood, May 7, 2009; 113(19): 4627 - 4636.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
F. C. Kimberley, L. van Bostelen, K. Cameron, G. Hardenberg, J. A. Marquart, M. Hahne, and J. P. Medema
The proteoglycan (heparan sulfate proteoglycan) binding domain of APRIL serves as a platform for ligand multimerization and cross-linking
FASEB J, May 1, 2009; 23(5): 1584 - 1595.
[Abstract] [Full Text] [PDF]


Home page
Ann Rheum DisHome page
D-A Landau, M Rosenzwajg, D Saadoun, D Klatzmann, and P Cacoub
The B lymphocyte stimulator receptor-ligand system in hepatitis C virus-induced B cell clonal disorders
Ann Rheum Dis, March 1, 2009; 68(3): 337 - 344.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
M. Thurau, G. Marquardt, N. Gonin-Laurent, K. Weinlander, E. Naschberger, R. Jochmann, K. R. Alkharsah, T. F. Schulz, M. Thome, F. Neipel, et al.
Viral Inhibitor of Apoptosis vFLIP/K13 Protects Endothelial Cells against Superoxide-Induced Cell Death
J. Virol., January 15, 2009; 83(2): 598 - 611.
[Abstract] [Full Text] [PDF]


Home page
Mol Hum ReprodHome page
S. Assou, D. Haouzi, K. Mahmoud, A. Aouacheria, Y. Guillemin, V. Pantesco, T. Reme, H. Dechaud, J. De Vos, and S. Hamamah
A non-invasive test for assessing embryo potential by gene expression profiles of human cumulus cells: a proof of concept study
Mol. Hum. Reprod., December 1, 2008; 14(12): 711 - 719.
[Abstract] [Full Text] [PDF]


Home page
haematolHome page
D. Bonci, M. Musumeci, V. Coppola, A. Addario, C. Conticello, M. Hahne, M. Gulisano, F. Grignani, and R. De Maria
Blocking the APRIL circuit enhances acute myeloid leukemia cell chemosensitivity
Haematologica, December 1, 2008; 93(12): 1899 - 1902.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. L. Scholz, J. E. Crowley, M. M. Tomayko, N. Steinel, P. J. O'Neill, W. J. Quinn III, R. Goenka, J. P. Miller, Y. H. Cho, V. Long, et al.
BLyS inhibition eliminates primary B cells but leaves natural and acquired humoral immunity intact
PNAS, October 7, 2008; 105(40): 15517 - 15522.
[Abstract] [Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
J. C. Nossent, S. Lester, D. Zahra, C. R. Mackay, and M. Rischmueller
Polymorphism in the 5' regulatory region of the B-lymphocyte activating factor gene is associated with the Ro/La autoantibody response and serum BAFF levels in primary Sjogren's syndrome
Rheumatology, September 1, 2008; 47(9): 1311 - 1316.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. M. Ranuncolo, L. Wang, J. M. Polo, T. Dell'Oso, J. Dierov, T. J. Gaymes, F. Rassool, M. Carroll, and A. Melnick
BCL6-mediated Attenuation of DNA Damage Sensing Triggers Growth Arrest and Senescence through a p53-dependent Pathway in a Cell Context-dependent Manner
J. Biol. Chem., August 15, 2008; 283(33): 22565 - 22572.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
G. Hardenberg, L. Fernandez, J. Hendriks, K. Chebli, C. Jacquet, M. Sitbon, M. Hahne, and J. P. Medema
APRIL facilitates viral-induced erythroleukemia but is dispensable for T cell immunity and lymphomagenesis
J. Leukoc. Biol., August 1, 2008; 84(2): 380 - 388.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
M. Krumbholz, H. Faber, F. Steinmeyer, L.-A. Hoffmann, T. Kumpfel, H. Pellkofer, T. Derfuss, C. Ionescu, M. Starck, C. Hafner, et al.
Interferon-{beta} increases BAFF levels in multiple sclerosis: implications for B cell autoimmunity
Brain, June 1, 2008; 131(6): 1455 - 1463.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
M. K. Tee, J.-L. Vigne, J. Yu, and R. N. Taylor
Natural and recombinant human glycodelin activate a proapoptotic gene cascade in monocyte cells
J. Leukoc. Biol., April 1, 2008; 83(4): 843 - 852.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
S.-W. Kim, D. W. Oleksyn, R. M. Rossi, C. T. Jordan, I. Sanz, L. Chen, and J. Zhao
Protein kinase C-associated kinase is required for NF-{kappa}B signaling and survival in diffuse large B-cell lymphoma cells
Blood, February 1, 2008; 111(3): 1644 - 1653.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
R. T. Woodland, C. J. Fox, M. R. Schmidt, P. S. Hammerman, J. T. Opferman, S. J. Korsmeyer, D. M. Hilbert, and C. B. Thompson
Multiple signaling pathways promote B lymphocyte stimulator dependent B-cell growth and survival
Blood, January 15, 2008; 111(2): 750 - 760.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
V. T. Chu, P. Enghard, G. Riemekasten, and C. Berek
In Vitro and In Vivo Activation Induces BAFF and APRIL Expression in B Cells
J. Immunol., November 1, 2007; 179(9): 5947 - 5957.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
P. Neri, S. Kumar, M. T. Fulciniti, S. Vallet, S. Chhetri, S. Mukherjee, Y. Tai, D. Chauhan, P. Tassone, S. Venuta, et al.
Neutralizing B-Cell Activating Factor Antibody Improves Survival and Inhibits Osteoclastogenesis in a Severe Combined Immunodeficient Human Multiple Myeloma Model
Clin. Cancer Res., October 1, 2007; 13(19): 5903 - 5909.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
A. Weigert, N. Tzieply, A. von Knethen, A. M. Johann, H. Schmidt, G. Geisslinger, and B. Brune
Tumor Cell Apoptosis Polarizes Macrophages Role of Sphingosine-1-Phosphate
Mol. Biol. Cell, October 1, 2007; 18(10): 3810 - 3819.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
C. G. Mueller, C. Boix, W.-H. Kwan, C. Daussy, E. Fournier, W. H. Fridman, and T. J. Molina
Critical role of monocytes to support normal B cell and diffuse large B cell lymphoma survival and proliferation
J. Leukoc. Biol., September 1, 2007; 82(3): 567 - 575.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
L. S. Treml, G. Carlesso, K. L. Hoek, J. E. Stadanlick, T. Kambayashi, R. J. Bram, M. P. Cancro, and W. N. Khan
TLR Stimulation Modifies BLyS Receptor Expression in Follicular and Marginal Zone B Cells
J. Immunol., June 15, 2007; 178(12): 7531 - 7539.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. R. Darce, B. K. Arendt, S. K. Chang, and D. F. Jelinek
Divergent Effects of BAFF on Human Memory B Cell Differentiation into Ig-Secreting Cells
J. Immunol., May 1, 2007; 178(9): 5612 - 5622.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
D. M. Mills, G. Bonizzi, M. Karin, and R. C. Rickert
Regulation of late B cell differentiation by intrinsic IKK{alpha}-dependent signals
PNAS, April 10, 2007; 104(15): 6359 - 6364.
[Abstract] [Full Text] [PDF]


Home page
haematolHome page
Y. Oki, G. V. Georgakis, T.-S. Migone, L. W. Kwak, and A. Younes
Prognostic significance of serum B-lymphocyte stimulator level in Hodgkin's lymphoma
Haematologica, February 1, 2007; 92(2): 269 - 270.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
S. Kothlow, I. Morgenroth, Y. Graef, K. Schneider, I. Riehl, P. Staeheli, P. Schneider, and B. Kaspers
Unique and conserved functions of B cell-activating factor of the TNF family (BAFF) in the chicken
Int. Immunol., February 1, 2007; 19(2): 203 - 215.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
M.-A. Lyu, L. H. Cheung, W. N. Hittelman, J. W. Marks, R. C.T. Aguiar, and M. G. Rosenblum
The rGel/BLyS fusion toxin specifically targets malignant B cells expressing the BLyS receptors BAFF-R, TACI, and BCMA
Mol. Cancer Ther., February 1, 2007; 6(2): 460 - 470.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
A. Chiu, W. Xu, B. He, S. R. Dillon, J. A. Gross, E. Sievers, X. Qiao, P. Santini, E. Hyjek, J.-w. Lee, et al.
Hodgkin lymphoma cells express TACI and BCMA receptors and generate survival and proliferation signals in response to BAFF and APRIL
Blood, January 15, 2007; 109(2): 729 - 739.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
T. Endo, M. Nishio, T. Enzler, H. B. Cottam, T. Fukuda, D. F. James, M. Karin, and T. J. Kipps
BAFF and APRIL support chronic lymphocytic leukemia B-cell survival through activation of the canonical NF-{kappa}B pathway
Blood, January 15, 2007; 109(2): 703 - 710.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
P. Ame-Thomas, H. Maby-El Hajjami, C. Monvoisin, R. Jean, D. Monnier, S. Caulet-Maugendre, T. Guillaudeux, T. Lamy, T. Fest, and K. Tarte
Human mesenchymal stem cells isolated from bone marrow and lymphoid organs support tumor B-cell growth: role of stromal cells in follicular lymphoma pathogenesis
Blood, January 15, 2007; 109(2): 693 - 702.
[Abstract] [Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
M. Fabris, L. Quartuccio, S. Sacco, G. De Marchi, G. Pozzato, C. Mazzaro, G. Ferraccioli, T. S. Migone, and S. De Vita
B-Lymphocyte stimulator (BLyS) up-regulation in mixed cryoglobulinaemia syndrome and hepatitis-C virus infection
Rheumatology, January 1, 2007; 46(1): 37 - 43.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
J. Schwaller, P. Schneider, P. Mhawech-Fauceglia, T. McKee, S. Myit, T. Matthes, J. Tschopp, O. Donze, F.-A. Le Gal, and B. Huard
Neutrophil-derived APRIL concentrated in tumor lesions by proteoglycans correlates with human B-cell lymphoma aggressiveness
Blood, January 1, 2007; 109(1): 331 - 338.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
S. K. Chang, B. K. Arendt, J. R. Darce, X. Wu, and D. F. Jelinek
A role for BLyS in the activation of innate immune cells
Blood, October 15, 2006; 108(8): 2687 - 2694.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
Y.-T. Tai, X.-F. Li, I. Breitkreutz, W. Song, P. Neri, L. Catley, K. Podar, T. Hideshima, D. Chauhan, N. Raje, et al.
Role of B-Cell-Activating Factor in Adhesion and Growth of Human Multiple Myeloma Cells in the Bone Marrow Microenvironment.
Cancer Res., July 1, 2006; 66(13): 6675 - 6682.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. P. Miller, J. E. Stadanlick, and M. P. Cancro
Space, Selection, and Surveillance: Setting Boundaries with BLyS.
J. Immunol., June 1, 2006; 176(11): 6405 - 6410.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
B. He, X. Qiao, P. J. Klasse, A. Chiu, A. Chadburn, D. M. Knowles, J. P. Moore, and A. Cerutti
HIV-1 Envelope Triggers Polyclonal Ig Class Switch Recombination through a CD40-Independent Mechanism Involving BAFF and C-Type Lectin Receptors
J. Immunol., April 1, 2006; 176(7): 3931 - 3941.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
S. F. Elsawa, A. J. Novak, D. M. Grote, S. C. Ziesmer, T. E. Witzig, R. A. Kyle, S. R. Dillon, B. Harder, J. A. Gross, and S. M. Ansell
B-lymphocyte stimulator (BLyS) stimulates immunoglobulin production and malignant B-cell growth in Waldenstrom macroglobulinemia
Blood, April 1, 2006; 107(7): 2882 - 2888.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
A. J. Novak, D. M. Grote, S. C. Ziesmer, M. P. Kline, M. K. Manske, S. Slager, T. E. Witzig, T. Shanafelt, T. G. Call, N. E. Kay, et al.
Elevated Serum B-Lymphocyte Stimulator Levels in Patients With Familial Lymphoproliferative Disorders
J. Clin. Oncol., February 20, 2006; 24(6): 983 - 987.
[Abstract] [Full Text] [PDF]


Home page
ASH ANNUAL MEETING ABSTRACTSHome page
A. Chiu, X. Qiao, B. He, E. Hyjjek, J. Lee, E. Cesarman, A. Chadburn, D. M. Knowles, and A. Cerutti
The TNF Family Members BAFF and APRIL Play an Important Role in Hodgkin Lymphoma.
Blood (ASH Annual Meeting Abstracts), November 16, 2005; 106(11): 22 - 22.
[Abstract]


Home page
J. Immunol.Home page
M. Yang, H. Hase, D. Legarda-Addison, L. Varughese, B. Seed, and A. T. Ting
B Cell Maturation Antigen, the Receptor for a Proliferation-Inducing Ligand and B Cell-Activating Factor of the TNF Family, Induces Antigen Presentation in B Cells
J. Immunol., September 1, 2005; 175(5): 2814 - 2824.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. Nishio, T. Endo, N. Tsukada, J. Ohata, S. Kitada, J. C. Reed, N. J. Zvaifler, and T. J. Kipps
Nurselike cells express BAFF and APRIL, which can promote survival of chronic lymphocytic leukemia cells via a paracrine pathway distinct from that of SDF-1{alpha}
Blood, August 1, 2005; 106(3): 1012 - 1020.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. L. Gavin, B. Duong, P. Skog, D. Ait-Azzouzene, D. R. Greaves, M. L. Scott, and D. Nemazee
{Delta}BAFF, a Splice Isoform of BAFF, Opposes Full-Length BAFF Activity In Vivo in Transgenic Mouse Models
J. Immunol., July 1, 2005; 175(1): 319 - 328.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
X. Zhang, C.-S. Park, S.-O. Yoon, L. Li, Y.-M. Hsu, C. Ambrose, and Y. S. Choi
BAFF supports human B cell differentiation in the lymphoid follicles through distinct receptors
Int. Immunol., June 1, 2005; 17(6): 779 - 788.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
K. Ingold, A. Zumsteg, A. Tardivel, B. Huard, Q.-G. Steiner, T. G. Cachero, F. Qiang, L. Gorelik, S. L. Kalled, H. Acha-Orbea, et al.
Identification of proteoglycans as the APRIL-specific binding partners
J. Exp. Med., May 2, 2005; 201(9): 1375 - 1383.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. A. Ogden, J. D. Pound, B. K. Batth, S. Owens, I. Johannessen, K. Wood, and C. D. Gregory
Enhanced Apoptotic Cell Clearance Capacity and B Cell Survival Factor Production by IL-10-Activated Macrophages: Implications for Burkitt's Lymphoma
J. Immunol., March 1, 2005; 174(5): 3015 - 3023.
[Abstract] [Full Text] [PDF]


Home page
Ann Rheum DisHome page
N M Van Mello, S R Pillemer, P P Tak, and V Sankar
B cell MALT lymphoma diagnosed by labial minor salivary gland biopsy in patients screened for Sjogren's syndrome
Ann Rheum Dis, March 1, 2005; 64(3): 471 - 473.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
S. Monti, K. J. Savage, J. L. Kutok, F. Feuerhake, P. Kurtin, M. Mihm, B. Wu, L. Pasqualucci, D. Neuberg, R. C. T. Aguiar, et al.
Molecular profiling of diffuse large B-cell lymphoma identifies robust subtypes including one characterized by host inflammatory response
Blood, March 1, 2005; 105(5): 1851 - 1861.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Q. Gong, Q. Ou, S. Ye, W. P. Lee, J. Cornelius, L. Diehl, W. Y. Lin, Z. Hu, Y. Lu, Y. Chen, et al.
Importance of Cellular Microenvironment and Circulatory Dynamics in B Cell Immunotherapy
J. Immunol., January 15, 2005; 174(2): 817 - 826.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
J. Q. Zhang, C. Okumura, T. McCarty, M. S. Shin, P. Mukhopadhyay, M. Hori, T. A. Torrey, Z. Naghashfar, J. X. Zhou, C. H. Lee, et al.
Evidence for Selective Transformation of Autoreactive Immature Plasma Cells in Mice Deficient in Fasl
J. Exp. Med., December 6, 2004; 200(11): 1467 - 1478.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
A. J. Novak, D. M. Grote, M. Stenson, S. C. Ziesmer, T. E. Witzig, T. M. Habermann, B. Harder, K. M. Ristow, R. J. Bram, D. F. Jelinek, et al.
Expression of BLyS and its receptors in B-cell non-Hodgkin lymphoma: correlation with disease activity and patient outcome
Blood, October 15, 2004; 104(8): 2247 - 2253.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Y. Sasaki, S. Casola, J. L. Kutok, K. Rajewsky, and M. Schmidt-Supprian
TNF Family Member B Cell-Activating Factor (BAFF) Receptor-Dependent and -Independent Roles for BAFF in B Cell Physiology
J. Immunol., August 15, 2004; 173(4): 2245 - 2252.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2004 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2004 by The American Association of Immunologists, Inc. All rights reserved.